CELLFE, INC

Building the Future Through Microfluidics

Alameda, United States · Founded 2019 · $25.6M raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$25.6M
Last Round
$22.0M Series ASep 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

CellFE is a biotechnology company developing microfluidic-based solutions for scalable cell therapy manufacturing. Their Ryva Mechanoporation System enables efficient, non-viral delivery of gene-editing molecules into human cells with high viability and payload capacity. The platform targets research through commercial-scale production of advanced cell therapies.

Summary

CELLFE, INC is a Biotech company based in Alameda, United States, founded in 2019. It has raised $25.6M in total across 2 rounds, most recently a $22.0M Series A round in Sep 2023. Investors include M Ventures, GreatPoint Ventures and Riverine Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2023
$22.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CELLFE, INC on Indexed.vc
<a href="https://indexed.vc/companies/cellfe-inc"><img src="https://indexed.vc/api/badge/company/cellfe-inc" alt="CELLFE, INC on Indexed.vc" width="260" height="76" /></a>